JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Stratasys
SSYS
$781M
| $2.09M | ﹤0.01% |
126,653
+78,078
| +161% | +$1.1M |
|
|
OSH
3352
CALL
DELISTED
Oak Street Health, Inc.
OSH
| $2.09M | ﹤0.01% |
54,100
+50,100
| +1,253% | +$1.62M |
|
|
CORS.U
3353
DELISTED
Corsair Partnering Corporation Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CORS.U
| $2.09M | ﹤0.01% |
+205,014
| New | +$2.09M |
|
3354
PUT
Mueller Water Products
MWA
$3.99B
| $2.09M | ﹤0.01% |
150,000
-30,000
| -17% | -$391K |
|
3355
Parsons
PSN
$5.12B
| $2.09M | ﹤0.01% |
46,726
+7,144
| +18% | +$314K |
|
|
SHAP
3356
DELISTED
Spree Acquisition Corp. 1 Limited
SHAP
| $2.09M | ﹤0.01% |
200,000
-140,000
| -41% | -$1.45M |
|
3357
Tennant Co
TNC
$1.17B
| $2.08M | ﹤0.01% |
30,332
+9,024
| +42% | +$612K |
|
3358
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.36B
| $2.08M | ﹤0.01% |
28,380
+2,301
| +9% | +$159K |
|
3359
OrthoPediatrics
KIDS
$648M
| $2.08M | ﹤0.01% |
46,853
+4,285
| +10% | +$189K |
|
3360
PUT
Blackrock
BLK
$182B
| $2.07M | ﹤0.01% |
3,100
-7,900
| -72% | -$5.56M |
|
|
DVAX
3361
DELISTED
Dynavax Technologies
DVAX
| $2.07M | ﹤0.01% |
211,421
+38,374
| +22% | +$410K |
|
3362
CALL
McDonald's
MCD
$193B
| $2.07M | ﹤0.01% |
7,400
-70,900
| -91% | -$19M |
|
3363
iShares International Equity Factor ETF
INTF
$3.77B
| $2.07M | ﹤0.01% |
77,997
+24,223
| +45% | +$631K |
|
3364
Veracyte
VCYT
$3.32B
| $2.07M | ﹤0.01% |
92,654
-292,795
| -76% | -$7.08M |
|
3365
Recursion Pharmaceuticals
RXRX
$1.69B
| $2.06M | ﹤0.01% |
309,514
+136,178
| +79% | +$1.08M |
|
3366
OptimizeRx
OPRX
$164M
| $2.06M | ﹤0.01% |
140,978
-2,117
| -1% | -$35.4K |
|
|
MODN
3367
DELISTED
MODEL N, INC.
MODN
| $2.06M | ﹤0.01% |
61,422
+5,853
| +11% | +$213K |
|
3368
Triumph Financial Inc
TFIN
$1.87B
| $2.05M | ﹤0.01% |
35,321
+4,828
| +16% | +$277K |
|
3369
CALL
Entegris
ENTG
$24.7B
| $2.05M | ﹤0.01% |
25,000
-175,000
| -88% | -$14.2M |
|
|
ZYXI
3370
DELISTED
Zynex
ZYXI
| $2.05M | ﹤0.01% |
170,568
+6,235
| +4% | +$81.5K |
|
3371
EverCommerce
EVCM
$1.8B
| $2.04M | ﹤0.01% |
193,319
-30,140
| -13% | -$291K |
|
3372
flyExclusive
FLYX
$129M
| $2.04M | ﹤0.01% |
+200,000
| New | +$2.02M |
|
|
NKGN
3373
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| $2.03M | ﹤0.01% |
200,557
-234,433
| -54% | -$2.37M |
|
3374
CALL
CarGurus
CARG
$3.33B
| $2.03M | ﹤0.01% |
+108,600
| New | +$1.85M |
|
3375
CALL
Honeywell
HON
$74.2B
| $2.03M | ﹤0.01% |
11,247
-58,142
| -84% | -$10.9M |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.